Israel Chemicals Ltd (ICL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 6,841,000 | 7,536,000 | 10,015,000 | 6,955,000 | 5,043,000 |
| Cost of Goods | 4,585,000 | 4,865,000 | 4,983,000 | 4,344,000 | 3,553,000 |
| Gross Profit | 2,256,000 | 2,671,000 | 5,032,000 | 2,611,000 | 1,490,000 |
| Operating Expenses | 1,481,000 | 1,530,000 | 1,516,000 | 1,401,000 | 1,288,000 |
| Operating Income | 775,000 | 1,141,000 | 3,516,000 | 1,210,000 | 202,000 |
| Interest Expense | 181,000 | 259,000 | 327,000 | 216,000 | 219,000 |
| Other Income | 42,000 | 92,000 | 215,000 | 98,000 | 66,000 |
| Pre-tax Income | 636,000 | 974,000 | 3,404,000 | 1,092,000 | 49,000 |
| Income Tax | 172,000 | 287,000 | 1,185,000 | 260,000 | 25,000 |
| Net Income Continuous | 464,000 | 687,000 | 2,219,000 | 832,000 | 24,000 |
| Minority Interests | 57,000 | 40,000 | 60,000 | 49,000 | 13,000 |
| Net Income | $407,000 | $647,000 | $2,159,000 | $783,000 | $11,000 |
| EPS Basic Total Ops | 0.32 | 0.50 | 1.68 | 0.61 | 0.01 |
| EPS Basic Continuous Ops | 0.36 | 0.53 | 1.72 | 0.65 | 0.02 |
| EPS Diluted Total Ops | 0.32 | 0.50 | 1.67 | 0.60 | 0.01 |
| EPS Diluted Continuous Ops | 0.36 | 0.53 | 1.72 | 0.65 | 0.02 |
| EPS Diluted Before Non-Recurring Items | 0.38 | 0.55 | 1.82 | 0.64 | 0.20 |
| EBITDA(a) | $1,371,000 | $1,677,000 | $4,014,000 | $1,700,000 | $691,000 |